An increase in cell number at completion of therapy may develop as an indicator of early relapse

@article{Pachmann2007AnII,
  title={An increase in cell number at completion of therapy may develop as an indicator of early relapse},
  author={K. Pachmann and R. Dengler and K. Lobodasch and Frank Fr{\"o}hlich and T. Kroll and M. Rengsberger and R. Schubert and U. Pachmann},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2007},
  volume={134},
  pages={59-65}
}
PurposeTreatment efficiency of adjuvant therapy in breast cancer is only revealed after several years by statistical evaluation and gives no answer for the individual patient. We here present a method to analyze the response to adjuvant chemotherapy online in individual patients.Methods/resultsIn 25 consecutive non-metastatic primary breast cancer patients adjuvant fluorouracil/epirubicin/cyclophosphamid (FEC) or EC followed by taxane (EC-T) or cyclophosphamid/methotrexate/fluorouracil (CMF… Expand
View on Springer
static1.squarespace.com
32 Citations
Background Citations
11
Methods Citations
3
Results Citations
1

32 Citations

Citation Type

Citation Type

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck.
The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy response.
Review: Biological relevance of disseminated tumor cells in cancer patients
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma
Circulating Tumor Cells: Detection Methods and Potential Clinical Application in Breast Cancer
Clinical significance of circulating tumor cells in breast cancer patients
Treatment of advanced solid tumours with NSAIDs: Correlation of quantitative monitoring of circulating tumour cells and positron emission tomography-computed tomography imaging
Quantification of circulating melanoma cells
Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients.
...
1
2
3
4
...

References

SHOWING 1-10 OF 31 REFERENCES
Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapse.
Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC® is a predictor for relapse: A preliminary report
Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
[Detection of disseminated tumor cells in bone marrow--currently of no practical therapeutic value].
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity
...
1
2
3
4
...